2020
DOI: 10.1371/journal.pntd.0008704
|View full text |Cite
|
Sign up to set email alerts
|

The neglected challenge: Vaccination against rickettsiae

Abstract: Over the last decades, rickettsioses are emerging worldwide. These diseases are caused by intracellular bacteria. Although rickettsioses can be treated with antibiotics, a vaccine against rickettsiae is highly desired for several reasons. Rickettsioses are highly prevalent, especially in poor countries, and there are indications of the development of antibiotic resistance. In addition, some rickettsiae can persist and cause recurrent disease. The development of a vaccine requires the understanding of the immun… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
13
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 14 publications
(13 citation statements)
references
References 204 publications
(436 reference statements)
0
13
0
Order By: Relevance
“…As with other Rickettsioses, doxycycline is the treatment of choice although its effect weakens later in infection. Effective vaccines do not exist (Osterloh, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…As with other Rickettsioses, doxycycline is the treatment of choice although its effect weakens later in infection. Effective vaccines do not exist (Osterloh, 2020).…”
Section: Introductionmentioning
confidence: 99%
“…This approach should be the choice for high-risk travellers, such as backpackers, trekkers, and cave explorers, especially in areas where access to a medical facility is limited. Currently, vaccination against rickettsiosis has been investigated in an experimental animal model [40]. Unfortunately, to date, there is no promising human vaccine in the drug pipeline.…”
Section: Travel-associated Rickettsiosismentioning
confidence: 99%
“…There are currently no vaccines commercially available for rickettsioses [141]. Previous attempts for R. conorii vaccine development failed to provide long lasting immunity [142].…”
Section: Preventionmentioning
confidence: 99%